+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Investigation Report on China's Mycophenolate Mofetil Market 2021-2025

  • PDF Icon

    Report

  • 50 Pages
  • July 2021
  • Region: China
  • China Research & Intelligence
  • ID: 5393435
Mycophenolate mofetil is a powerful inhibitor of lymphocyte proliferation and has been used to prevent acute rejection of allografts since the early 1990s. Mycophenolate mofetil is also widely used as a glucocorticoid reducing agent to treat patients with various rheumatic diseases, including systemic lupus erythematosus (SLE), systemic sclerosis (SSc), inflammation Myopathy and some systemic vasculitis.

Mycophenolate mofetil was developed by Roche Pharmaceuticals Co., Ltd., and the trade name of Mycophenolate mofetil from Roche is CELLCEPT. CELLCEPT was first approved by the NMPA for listing in China in 2004, and then generic drugs from local Chinese companies have also been listed successively. By 2020, there are many manufacturers in China's mycophenolate mofetil market, among which Shanghai Roche Pharmaceuticals Co., Ltd. has the highest sales market share.

According to the research market, the sales of mycophenolate mofetil in the Chinese market have increased year by year from 2016 to 2020. In 2020, due to the impact of the Covid-19 epidemic on the overall medical diagnosis and treatment services, the growth rate of sales has decreased. However, the sales still reached CNY 921 million, with a CAGR of 6.54% from 2016 to 2020.

The analyst expects that with the effective alleviation of the Covid-19 epidemic, the sales of mycophenolate mofetil in the Chinese market will have a restorative growth from 2021 to 2025. At the same time, compared with similar drugs, mycophenolate mofetil is safer and more effective. Based on these advantages, the sales volume and sales of mycophenolate mofetil in the Chinese market will continue to grow from 2021 to 2025.

Topics Covered:

  • The impact of COVID-19 on China's Mycophenolate Mofetil market
  • Sales value of China's Mycophenolate Mofetil 2016-2020
  • Competitive landscape of China's Mycophenolate Mofetil market
  • Prices of Mycophenolate Mofetil in China
  • Prices of Mycophenolate Mofetil in China by regions and manufacturers
  • Analysis on factors affecting the development of China's Mycophenolate Mofetil market
  • Prospect of China's Mycophenolate Mofetil market from 2021 to 2025

Table of Contents

1 Relevant Concept of Mycophenolate Mofetil
1.1 Indications for Mycophenolate Mofetil
1.2 Development of Mycophenolate Mofetil in China
1.3 Governmental Approval of Mycophenolate Mofetil in China
1.4 The Impact of COVID-19 on Mycophenolate Mofetil sales in China
2 Sales of Mycophenolate Mofetil in China, 2016-2020
2.1 Sales Value of Mycophenolate Mofetil
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Mycophenolate Mofetil
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Mycophenolate Mofetil by Dosage Form in China, 2016-2020
2.3.1 Capsules
2.3.2 Tablets
2.3.3 Dispersible Tablets
2.3.4 Ear Drops
2.3.5 Dry Suspension
3 Analysis of Major Mycophenolate Mofetil Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Mycophenolate Mofetil Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Shanghai Roche Pharmaceutical Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of CELLCEPT (Shanghai Roche Pharmaceutical Co., Ltd.’s Mycophenolate Mofetil) in China
3.3 Hangzhou Sino American Huadong Pharmaceutical Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Saikepin (Hangzhou Sino American Huadong Pharmaceutical Co., Ltd.’s Mycophenolate Mofetil) in China
3.4 Sinopharm Chuankang Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of Maikaofen (Sinopharm Chuankang Pharmaceutical Co., Ltd.’s Mycophenolate Mofetil) in China
3.5 Qionglai Tianyin Pharmaceutical Co., Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of Fuyi (Qionglai Tianyin Pharmaceutical Co., Ltd.’s Mycophenolate Mofetil) in China
3.6 Beijing Shuanglu Pharmaceutical Co., Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of Xinfutong (Beijing Shuanglu Pharmaceutical Co., Ltd.’s Mycophenolate Mofetil) in China
4 Prices of Mycophenolate Mofetil for Different Manufacturers in China, 2020-2021
4.1 Shanghai Roche Pharmaceutical Co., Ltd. (CELLCEPT)
4.2 Hangzhou Sino American Huadong Pharmaceutical Co., Ltd. (Saikepin)
4.3 Sinopharm Chuankang Pharmaceutical Co., Ltd. (Maikaofen)
4.4 Qionglai Tianyin Pharmaceutical Co., Ltd. (Fuyi)
4.5 Beijing Shuanglu Pharmaceutical Co., Ltd. (Xinfutong)
5 Prospect of Chinese Mycophenolate Mofetil Market, 2021-2025
5.1 Influential Factors of Chinese Mycophenolate Mofetil Market Development
5.1.1 The Impact of COVID-19 on Chinese Mycophenolate Mofetil Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
List of Charts
Chart Patent Information About Mycophenolate Mofetil Capsules Registration in China
Chart Patent Information About Mycophenolate Mofetil Tablets Registration in China
Chart Patent Information About Mycophenolate Mofetil Dispersible Tablets Registration in China
Chart Patent Information About Mycophenolate Mofetil Ear Drops Registration in China
Chart Patent Information About Mycophenolate Mofetil Dry Suspension Registration in China
Chart Sales Value of Mycophenolate Mofetil Capsules over the World
Chart Sales Value of Mycophenolate Mofetil Tablets over the World
Chart Sales Value of Mycophenolate Mofetil Dispersible Tablets over the World
Chart Sales Value of Mycophenolate Mofetil Ear Drops over the World
Chart Sales Value of Mycophenolate Mofetil Dry Suspension over the World
Chart Sales Value of Mycophenolate Mofetil Capsules in China, 2016-2020
Chart Sales Value of Mycophenolate Mofetil Tablets in China, 2016-2020
Chart Sales Value of Mycophenolate Mofetil Dispersible Tablets in China, 2016-2020
Chart Sales Value of Mycophenolate Mofetil Ear Drops in China, 2016-2020
Chart Sales Value of Mycophenolate Mofetil Dry Suspension in China, 2016-2020
Chart Sales Value of Mycophenolate Mofetil Capsules in China by Region, 2016-2020
Chart Sales Value of Mycophenolate Mofetil Tablets in China by Region, 2016-2020
Chart Sales Value of Mycophenolate Mofetil Dispersible Tablets in China by Region, 2016-2020
Chart Sales Value of Mycophenolate Mofetil Ear Drops in China by Region, 2016-2020
Chart Sales Value of Mycophenolate Mofetil Dry Suspension in China by Region, 2016-2020
Chart Sales Volume of Mycophenolate Mofetil Capsules in China, 2016-2020
Chart Sales Volume of Mycophenolate Mofetil Tablets in China, 2016-2020
Chart Sales Volume of Mycophenolate Mofetil Dispersible Tablets in China, 2016-2020
Chart Sales Volume of Mycophenolate Mofetil Ear Drops in China, 2016-2020
Chart Sales Volume of Mycophenolate Mofetil Dry Suspension in China, 2016-2020
Chart Sales Volume of Mycophenolate Mofetil Capsules in China by Region, 2016-2020
Chart Sales Volume of Mycophenolate Mofetil Tablets in China by Region, 2016-2020
Chart Sales Volume of Mycophenolate Mofetil Dispersible Tablets in China by Region, 2016-2020
Chart Sales Volume of Mycophenolate Mofetil Ear Drops in China by Region, 2016-2020
Chart Sales Volume of Mycophenolate Mofetil Dry Suspension in China by Region, 2016-2020
Chart Market Share by Sales Value of Top Mycophenolate Mofetil Capsules Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Mycophenolate Mofetil Tablets Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Mycophenolate Mofetil Dispersible Tablets Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Mycophenolate Mofetil Ear Drops Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Mycophenolate Mofetil Dry Suspension Manufacturers in China, 2016-2020

Samples

Loading
LOADING...

Companies Mentioned

  • Shanghai Roche Pharmaceutical Co., Ltd. (CELLCEPT)
  • Hangzhou Sino American Huadong Pharmaceutical Co., Ltd. (Saikepin)
  • Sinopharm Chuankang Pharmaceutical Co., Ltd. (Maikaofen)
  • Qionglai Tianyin Pharmaceutical Co., Ltd. (Fuyi)
  • Beijing Shuanglu Pharmaceutical Co., Ltd. (Xinfutong)

Methodology

Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.

Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.

Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.

The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.

The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.

1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.


 

Loading
LOADING...

Table Information